Sensitivity of the Natriuretic Peptide/cGMP System to Hyperammonaemia in Rat C6 Glioma Cells and GPNT Brain Endothelial Cells

Regan, Jacob; Mirczuk, Samantha; Scudder, Christopher; Stacey, Emily; Khan, Sabah; Powles, Torinn; Dennis-Berron, J. Sebastian; Ginley-Hidinger, Matthew; Mcgonnell, Imelda; Volk, Holger; Strickland, Rhiannon; Tivers, Michael; Lawson, Charlotte; Lipscomb, Victoria; Fowkes, Robert

Abstract

C-type natriuretic peptide (CNP) is the major natriuretic peptide of the central nervous system and acts via its selective guanylyl cyclase-B (GC-B) receptor to regulate cGMP production in neurons, astrocytes and endothelial cells. CNP is implicated in the regulation of neurogenesis, axonal bifurcation, as well as learning and memory. Several neurological disorders result in toxic concentrations of ammonia (hyperammonaemia), which can adversely affect astrocyte function. However, the relationship between CNP and hyperammonaemia is poorly understood. Here, we examine the molecular and pharmacological control of CNP in rat C6 glioma cells and rat GPNT brain endothelial cells, under conditions of hyperammonaemia. Concentration-dependent inhibition of C6 glioma cell proliferation by hyperammonaemia was unaffected by CNP co-treatment. Furthermore, hyperammonaemia pre-treatment (for 1 h and 24 h) caused a significant inhibition in subsequent CNP-stimulated cGMP accumulation in both C6 and GPNT cells, whereas nitric-oxide-dependent cGMP accumulation was not affected. CNP-stimulated cGMP efflux from C6 glioma cells was significantly reduced under conditions of hyperammonaemia, potentially via a mechanism involving changed in phosphodiesterase expression. Hyperammonaemia-stimulated ROS production was unaffected by CNP but enhanced by a nitric oxide donor in C6 cells. Extracellular vesicle production from C6 cells was enhanced by hyperammonaemia, and these vesicles caused impaired CNP-stimulated cGMP signalling in GPNT cells. Collectively, these data demonstrate functional interaction between CNP signalling and hyperammonaemia in C6 glioma and GPNT cells, but the exact mechanisms remain to be established.

Citation

Regan, J., Mirczuk, S., Scudder, C., Stacey, E., Khan, S., Powles, T., Dennis-Berron, J. S., Ginley-Hidinger, M., Mcgonnell, I., Volk, H., Strickland, R., Tivers, M., Lawson, C., Lipscomb, V., & Fowkes, R. (2021). Sensitivity of the Natriuretic Peptide/cGMP System to Hyperammonaemia in Rat C6 Glioma Cells and GPNT Brain Endothelial Cells. Cells, https://doi.org/10.3390/cells10020398

• Journal Article Type: Article
• Acceptance Date: Feb 11, 2021
• Online Publication Date: Feb 15, 2021
• Publication Date: Feb 15, 2021
• Deposit Date: Dec 26, 2020
• Publicly Available Date: Feb 22, 2021
• Journal: Cells
• Electronic ISSN: 2073-4409
• Publisher: MDPI
• Peer Reviewed: Peer Reviewed
• DOI: https://doi.org/10.3390/cells10020398
• Keywords: natriuretic peptides; cGMP; hyperammonaemia; astrocyte; neuroendocrinology; endothelial cells; extracellular vesicles
• Public URL: https://rvc-repository.worktribe.com/output/1442734
• Publisher URL: https://www.mdpi.com/2073-4409/10/2/398